MFN2
MFN2 (mitofusin 2, also known as CPRP1, KIAA0214, MARF and CMT2A2) is a GTPase of the mitochondrial outer membrane that mediates mitochondrial clustering and fusion. It helps maintain the mitochondrial network and is linked to mitophagy, ER stress signalling and peripheral neuropathy. Browse Assay Genie's current range of MFN2 research reagents below, or read on for the biology behind the target.
Mitochondria are highly dynamic organelles, and their morphology is set by the balance between fusion and fission. MFN2 is a GTPase of the mitochondrial outer membrane that mediates mitochondrial clustering and fusion. Membrane clustering requires its GTPase activity and may involve a major rearrangement of the coiled coil domains, while overexpression induces the formation of mitochondrial networks. The protein plays a central role in mitochondrial metabolism and may be associated with obesity and apoptosis.
Beyond fusion, MFN2 is involved in the clearance of damaged mitochondria by selective autophagy (mitophagy), and it is required for PRKN recruitment to dysfunctional mitochondria. It also contributes to control of the unfolded protein response upon ER stress, including activation of apoptosis and autophagy. It acts as an upstream regulator of EIF2AK3 and suppresses EIF2AK3 activation under basal conditions. In addition, it has an important role in regulating vascular smooth muscle cell proliferation.
The human MFN2 gene belongs to the mitofusin family and encodes a member of the dynamin-like GTPase superfamily (Dynamin/Fzo/YdjA family, mitofusin subfamily). Two transcript variants encode the same protein. Mutations in the gene cause Charcot-Marie-Tooth disease type 2A2 and hereditary motor and sensory neuropathy VI, both disorders of the peripheral nervous system, and defects have also been associated with early-onset stroke. MFN1 is a related mitofusin family member.
MFN2 mediates mitochondrial clustering and fusion, helping determine the equilibrium between fusion and fission that shapes mitochondrial morphology and the network.
MFN2 is involved in clearing damaged mitochondria by mitophagy and is required for PRKN recruitment to dysfunctional mitochondria.
MFN2 helps control the unfolded protein response, including apoptosis and autophagy, and suppresses EIF2AK3 activation under basal conditions.
Mutations in MFN2 cause Charcot-Marie-Tooth disease type 2A2, and the protein may play a role in obesity and vascular smooth muscle proliferation.
MFN2 is a mitochondrial outer membrane GTPase that mediates mitochondrial clustering and fusion. It also takes part in mitophagy, where it is required for PRKN recruitment to damaged mitochondria, and in the unfolded protein response during ER stress, where it suppresses basal EIF2AK3 activation.
The gene is also known as CPRP1, KIAA0214, MARF and CMT2A2, and the UniProt protein name is Mitofusin-2. The HGNC full name is mitofusin 2. Two transcript variants of the gene encode the same protein, so there is a single protein sequence.
Mutations in MFN2 cause Charcot-Marie-Tooth disease type 2A2 and hereditary motor and sensory neuropathy VI, and defects are associated with early-onset stroke. Mouse and rat both have an Mfn2 ortholog; check the datasheet of any product for its validated reactivity.
Other mitofusin family members and mitochondrial dynamics targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O95140; product specifications from Assay Genie datasheets.